BNP Paribas Financial Markets’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138K Sell
807
-7,375
-90% -$934K ﹤0.01% 4382
2026
Q1
$778K Sell
8,182
-8,216
-50% -$1.01M ﹤0.01% 3312
2025
Q4
$2.7M Sell
16,398
-5,007
-23% -$664K ﹤0.01% 2431
2025
Q3
$2.21M Buy
21,405
+21,085
+6,589% +$2.07M ﹤0.01% 2542
2025
Q2
$39.8K Buy
320
+290
+967% +$37.5K ﹤0.01% 4344
2025
Q1
$1.41K Hold
30
﹤0.01% 5026
2024
Q4
$951 Sell
30
-100
-77% -$2.85K ﹤0.01% 5087
2024
Q3
$2.82K Buy
+130
New +$1.87K ﹤0.01% 3872

Other funds holding NUTX

BNP Paribas Financial Markets's NUTX Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Nutex Health (NUTX) stake by 90% in Q2 2026, selling an estimated $934K and leaving 807 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #4382.

BNP Paribas Financial Markets first reported a position in NUTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.7M in Q4 2025. 141 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • BNP Paribas Financial Markets held 807 shares of Nutex Health worth $138K as of Q2 2026.
  • BNP Paribas Financial Markets sold 7,375 Nutex Health shares in Q2 2026, an estimated $934K.
  • Nutex Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4382 holding.
  • BNP Paribas Financial Markets first reported a position in Nutex Health in Q3 2024 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Nutex Health position peaked at $2.7M in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.